mRNA plus Lysate-loaded Dendritic Cell Vaccine(MD Anderson Cancer Center)

N/A

Report date: 2024/11/09 20:00:08

Base Information

Drug NamemRNA plus Lysate-loaded Dendritic Cell Vaccine(MD Anderson Cancer Center)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHemangiosarcoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesThe University Of Texas MD Anderson Cancer Center

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe University Of Texas MD Anderson Cancer Center

Active IndicationsN/A

Inactive IndicationsHemangiosarcoma

Other Information

ATC CodeN/A